Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Dr. Reddy's Laboratories Ltd ADR (RDY)

Dr. Reddy's Laboratories Ltd ADR (RDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,352,310
  • Shares Outstanding, K 166,878
  • Annual Sales, $ 2,992 M
  • Annual Income, $ 548,000 K
  • 60-Month Beta 0.58
  • Price/Sales 3.79
  • Price/Cash Flow 17.12
  • Price/Book 3.74
Trade RDY with:

Options Overview Details

View History
  • Implied Volatility 29.18% ( +0.74%)
  • Historical Volatility 20.00%
  • IV Percentile 78%
  • IV Rank 75.79%
  • IV High 38.28% on 10/18/23
  • IV Low 0.67% on 06/16/23
  • Put/Call Vol Ratio 1.21
  • Today's Volume 42
  • Volume Avg (30-Day) 14
  • Put/Call OI Ratio 0.44
  • Today's Open Interest 521
  • Open Int (30-Day) 544

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate 0.86
  • Number of Estimates 1
  • High Estimate 0.86
  • Low Estimate 0.86
  • Prior Year 0.70
  • Growth Rate Est. (year over year) +22.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
70.71 +4.67%
on 04/19/24
74.44 -0.56%
on 04/01/24
+0.61 (+0.83%)
since 03/25/24
3-Month
69.23 +6.92%
on 01/30/24
77.72 -4.76%
on 02/23/24
+4.55 (+6.55%)
since 01/25/24
52-Week
53.12 +39.34%
on 05/18/23
77.72 -4.76%
on 02/23/24
+14.75 (+24.89%)
since 04/25/23

Most Recent Stories

More News
2 overlooked stocks that crushed earnings but traded lower

As the third quarter 2023 earnings season ends, it's worth looking back to see which stocks may have been overlooked or mispriced on their results

BMY : 44.70 (-8.51%)
WHR : 94.97 (-10.13%)
BAC : 37.91 (-1.07%)
DB : 17.92 (+8.74%)
HSBC : 41.81 (+0.29%)
NVS : 99.06 (+0.72%)
PFE : 25.26 (-3.84%)
TEVA : 13.25 (+1.84%)
RDY : 74.02 (+4.37%)
Chart of the Day: What's Cooking at Dr. Reddy's Lab

The Chart of the Day belongs to integrated drug company Dr. Reddy's Laboratories (RDY) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy...

RDY : 74.02 (+4.37%)
Drugmaker GSK: Becoming a Healthier Value Stock

Up more than 25% in the last nine months, U.K. pharmaceutical company GSK PLC is slowly regaining favor with investors after the GSK lawsuit.

GSK : 40.91 (+0.12%)
RDY : 74.02 (+4.37%)
Dr. Reddy's (RDY) Q4 Earnings and Revenues Beat Estimates

Dr. Reddy's (RDY) reports better-than-expected fourth-quarter results where both earnings and revenues beat estimates.

RDY : 74.02 (+4.37%)
IMGN : 31.23 (unch)
AZYO : 1.4900 (+2.05%)
BTTX : 0.0090 (+15.38%)
Here's Why Doctor Reddy's (RDY) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

RDY : 74.02 (+4.37%)
Dr. Reddy's Laboratories Announces the Launch of Regadenoson Injection 0.4 mg/5 mL in the U.S.

Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as "Dr. Reddy's"), today announced the launch of Regadenoson Injection...

RDY : 74.02 (+4.37%)
Zacks.com featured highlights Insperity, Microchip Technology, Darden Restaurants, Dr. Reddy's and W.W. Grainger

Insperity, Microchip Technology, Darden Restaurants, Dr. Reddy's and W.W. Grainger have been highlighted in this Screen of The Week article.

RDY : 74.02 (+4.37%)
DRI : 156.54 (-0.04%)
MCHP : 92.21 (+1.69%)
GWW : 947.84 (-1.09%)
NSP : 108.93 (-0.54%)
Dr. Reddy's Laboratories Announces the Launch of Treprostinil Injection in the U.S.

Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as "Dr. Reddy's"), today announced the launch of Treprostinil Injection...

RDY : 74.02 (+4.37%)
Aditxt Signs Asset Purchase Agreement to Acquire Fifty Percent Ownership of Global Response Aid – with Rights to Manufacture and Market Broad-Spectrum Antiviral Drug Avigan

Aditxt,® Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, is pleased to announce...

RDY : 74.02 (+4.37%)
ADTX : 2.53 (+6.75%)
Strength Seen in Amphastar (AMPH): Can Its 6.4% Jump Turn into More Strength?

Amphastar (AMPH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road....

AMPH : 40.83 (-0.41%)
RDY : 74.02 (+4.37%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company engaged in providing affordable and innovative medicines since 1984. The company markets its products in countries like the U.S., the UK, Germany, India, Russia, Venezuela, Romania and South Africa. Dr. Reddy's operates through...

See More

Key Turning Points

3rd Resistance Point 75.54
2nd Resistance Point 74.93
1st Resistance Point 74.48
Last Price 74.02
1st Support Level 73.42
2nd Support Level 72.81
3rd Support Level 72.36

See More

52-Week High 77.72
Last Price 74.02
Fibonacci 61.8% 68.32
Fibonacci 50% 65.42
Fibonacci 38.2% 62.52
52-Week Low 53.12

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar